Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
| Autor: | Ozan Cengiz, Göksel Bengi, Hale Akpinar, Muhammet Ozer, Rumeysa Colak |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty prevalence Observational Study Inflammatory bowel disease 03 medical and health sciences 0302 clinical medicine Quality of life inflammatory bowel disease Internal medicine Remission phase Healthy control medicine Humans In patient 030212 general & internal medicine Irritable bowel syndrome Aged irritable bowel syndrome business.industry Rome IV General Medicine Middle Aged medicine.disease Inflammatory Bowel Diseases Ulcerative colitis digestive system diseases 030220 oncology & carcinogenesis Quality of Life Observational study Female Symptom Assessment business Research Article |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 |
| Popis: | Irritable bowel syndrome (IBS)-like symptoms tend to be common in inflammatory bowel disease (IBD) patients even during the long-standing remission phase, and quality of life (QOL) seem to reduce in IBD patients with such symptoms. Thus, the aim of this study was to define the prevalence of IBS-like symptoms in inactive IBD patients using Rome IV criteria and evaluate the effect of IBS-like symptoms on QOL. Total 137 patients with IBD (56 with ulcerative colitis (UC) and 81 with Crohn disease (CD), who had been in long-standing remission according to the clinical scoring system and 123 control participants were included. These patients completed questionnaires to evaluate IBS-like symptoms according to Rome IV criteria, and the impact of these symptoms on the QOL of inactive IBD patients was compared with and without IBS-like symptoms according to disease-specific inflammatory bowel disease questionnaire (IBDQ). Depending on our research, IBS-like symptoms were found in 32% (18/56) of patients with inactive UC, 35% (29/81) of patients with inactive CD, and 13.8% (17/123) of control participants (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|